Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,680 shares at $35.00 ($59K) on 2015-01-02, disclosed to the SEC on 2015-01-05.
Scheduled sale ($59k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 240 | $8K | 14.2% |
| 2 | $35.20 | 1,016 | $36K | 60.3% |
| 3 | $35.69 | 424 | $15K | 25.5% |
| Total | $35.30 avg | 1,680 | $59K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |